UNIVERSITY OF OKLAHOMA
OKLAHOMA CITY, Oklahoma
Total Received
$322.5M
Total Awards
132
State
Oklahoma
Last Updated
Mar 20, 2026
Yearly Funding Trend
$282.7M24
$36.3M25
$3.4M26
Top 50 Awards to UNIVERSITY OF OKLAHOMA
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_U19AI062629_075 MOLECULAR AND IMMUNOLOGIC ANALYSIS OF THE PATHOBIOLOGY OF HUMAN ANTHRAX - THE PRESENT APPLICATION IS A COMPETING RENEWAL OF A CCHI GRANT ON THE HUMAN IMMUNE RESPONSE TO BACILLUS A… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | OK-90 | 2024 | $45,237,628 |
ASST_NON_P20GM103636_075 EXPANDING EXCELLENCE IN DEVELOPMENTAL BIOLOGY IN OKLAHOMA - ABSTRACT OUR OVERALL GOAL IS TO STRENGTHEN OUR DEVELOPMENTAL BIOLOGY COBRE BY MENTORING FIVE NEWLY-RECRUITED INVESTIGAT… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | OK-90 | 2024 | $26,753,814 |
ASST_NON_UC2AR081032_075 ACCELERATING MEDICINES PARTNERSHIP-AUTOIMMUNE AND IMMUNOLOGIC DISEASE TISSUE RESEARCH CORE - PROJECT SUMMARY THE SUCCESSFUL ACCELERATING MEDICINES PARTNERSHIP IN RA/LUPUS (AMP1)… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | OK-90 | 2024 | $19,601,747 |
ASST_NON_P20GM139763_075 CENTER FOR CELLULAR METABOLISM RESEARCH IN OKLAHOMA - ALTERED CELLULAR METABOLISM CONTRIBUTES TO THE PATHOGENESIS OF MANY COMMON DISEASES, SUCH AS CARDIOVASCULAR DISEASE, CANCER,… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | OK-90 | 2024 | $15,159,612 |
ASST_NON_R01HL113326_075 CHARACTERIZATION OF EUROPEAN AMERICAN AND AFRICAN AMERICAN SARCOIDOSIS VIA IMMUNOGENETICS - ABSTRACT SARCOIDOSIS IS A GRANULOMATOUS INFLAMMATORY DISEASE OFTEN DUBBED A “MEDICAL M… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | OK-90 | 2024 | $8,739,694 |
ASST_NON_P30AR073750_075 OKLAHOMA RHEUMATIC DISEASE RESEARCH CORES CENTER - THE MISSION OF THE OKLAHOMA RHEUMATIC DISEASE RESEARCH CORES CENTER (ORDRCC) IS TO SUPPORT AND OPTIMIZE INTERACTIONS BETWEEN BAS… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $6,842,249 |
ASST_NON_R01HL101917_075 PROTEASE ACTIVATED RECEPTOR AND THROMBOMODULIN SIGNALING BY COAGULATION PROTEASES - PROJECT SUMMARY THROMBOMODULIN (TM) IS AN INTEGRAL MEMBRANE RECEPTOR ON ENDOTHELIAL CELLS WHICH… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | OK-90 | 2024 | $6,155,525 |
ASST_NON_R35HL144605_075 PROTEASE-MEDIATED VASCULAR INSTABILITY IN DEVELOPMENT AND DISEASE - PROJECT SUMMARY/ABSTRACT VASCULAR INTEGRITY IS CRITICAL FOR THE PREVENTION OF TISSUE EDEMA, THROMBOSIS, INFLAMM… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $5,894,456 |
ASST_NON_R01DK085691_075 COLON O-GLYCOSYLATED MUCUS IN THE HOMEOSTASIS OF MICROBIOTA AND HOST - OVER THE PAST 15 YEARS, OUR STUDIES HAVE ESTABLISHED O-GLYCANS AS CRUCIAL COMPONENTS OF THE COLONIC MUCUS BA… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $5,446,362 |
ASST_NON_P30GM149376_075 EXPANDING EXCELLENCE IN DEVELOPMENTAL BIOLOGY IN OKLAHOMA - ABSTRACT OVERALL DEVELOPMENTAL BIOLOGY RESEARCH IS FUNDAMENTAL TO PROGRESS IN DETERMINING THE MOLECULAR BASIS OF MANY D… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | OKLAHOMA CITY, OK-05 | 2024 | $4,887,004 |
ASST_NON_R35HL145237_075 TRANSLATIONAL CONTROL OF MEGAKARYOCYTE AND PLATELET GENE EXPRESSION IN DISEASE - OVERALL SUMMARY/ABSTRACT THIS OUTSTANDING INVESTIGATOR AWARD R35 PROGRAM ADDRESSES PREVIOUSLY-UNEX… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | OK-90 | 2024 | $4,723,210 |
ASST_NON_R01AI156724_075 DISEASE AND RACE SPECIFIC SINGLE-CELL EPIGENETIC MECHANISMS IN HUMAN SLE - PROJECT SUMMARY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IS A PROTOTYPIC AUTOIMMUNE DISEASE CHARACTERIZED BY D… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $4,125,381 |
ASST_NON_R01HL131652_075 DEFINING THE MECHANISMS OF LYMPHATIC VASCULAR GROWTH AND FUNCTION - PROJECT SUMMARY/ABSTRACT GROWTH OF LYMPHATIC VESSELS FROM PRE-EXISTING VESSELS IS ACHIEVED VIA LYMPHANGIOGENESI… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | OK-90 | 2024 | $3,894,760 |
ASST_NON_U01AI176244_075 AUTOIMMUNE DRIVERS AND PROTECTORS TEAM SCIENCE (ADAPTS) - PROJECT SUMMARY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IS A HETEROGENEOUS, SYSTEMIC AUTOIMMUNE DISEASE THAT CAUSES SIGNIFICA… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $3,860,822 |
ASST_NON_R01AR073855_075 DISCOVERY AND CHARACTERIZATION OF GENETIC RISK LOCI IN SJOGREN'S SYNDROME - ABSTRACT SJÖGREN’S SYNDROME (SS) IS A COMPLEX RHEUMATIC DISORDER DISTINGUISHED BY AUTOIMMUNE TARGETING… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | OK-90 | 2024 | $3,706,085 |
ASST_NON_R01AR076440_075 PERIPHERAL BLOOD MONONUCLEAR CELL EPIGENETIC ASSOCIATIONS IN AND BIOMARKERS FOR KNEE OSTEOARTHRITIS DEVELOPMENT AND PROGRESSION - PROJECT SUMMARY / ABSTRACT THE OBJECTIVE OF THE P… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | OK-90 | 2024 | $3,603,670 |
ASST_NON_R01AI191517_075 FUNCTIONAL AND MECHANISTIC CHARACTERIZATION OF LUPUS SUSCEPTIBILITY - PROJECT ABSTRACT SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IS A COMPLEX AUTOIMMUNE DISEASE CHARACTERIZED BY CHRONIC… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | OK-90 | 2025 | $3,364,935 |
ASST_NON_R01AR060366_075 MECHANISTIC CHARACTERIZATION OF GWAS LOCI IN SLE - DESCRIPTION (PROVIDED BY APPLICANT): SYSTEMIC LUPUS ERYTHEMATOSUS (SLE OR LUPUS) IS A DEBILITATING AUTOIMMUNE DISEASE WITH… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $3,302,146 |
ASST_NON_R01AR073606_075 EPIGENOME-GUIDED CAUSAL VARIANT DISCOVERY AND MECHANISMS - PROJECT SUMMARY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IS A PROTOTYPIC AUTOIMMUNE DISEASE CHARACTERIZED BY DYSREGULATED INTE… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | OK-90 | 2025 | $3,262,348 |
ASST_NON_R35GM126980_075 UNDERSTANDING CELL DIVISION - CELL DIVISION INVOLVES COMPLEX INTERACTIVE PATHWAYS THAT COORDINATE CHROMOSOME MOVEMENTS WITH CELL CYCLE TRANSITIONS. WHILE MANY REGULATORS THAT MODU… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | OK-90 | 2024 | $3,238,787 |
ASST_NON_R01AI132532_075 IKAROS FAMILY GENES AND LUPUS SUSCEPTIBILITY ACROSS ETHNICALLY DIVERSE POPULATIONS - PROJECT SUMMARY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IS A COMPLEX AUTOIMMUNE DISEASE WITH A SUBS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $3,191,344 |
ASST_NON_R01GM101250_075 REGULATION OF CHROMOSOME COHESION DURING CELL CYCLE PROGRESSION - IN METAZOANS, THE COHESIN COMPLEX PLAYS CRITICAL ROLES IN MANY FUNDAMENTAL ASPECTS OF GENOME STRUCTURE AND MAINTE… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | OKLAHOMA CITY, OK-05 | 2024 | $3,181,940 |
ASST_NON_R01AI168355_075 COMPLEMENT C5 INHIBITION AS SEPSIS THERAPY - PROJECT SUMMARY SEPSIS IS A LIFE-THREATENING ORGAN DYSFUNCTION CAUSED BY DYSREGULATED HOST RESPONSE TO INFECTION. SEPSIS IS A LEADING… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $3,167,080 |
ASST_NON_R01AI190169_075 RESOLVING THE MECHANISMS OF IFIH1 RISK VARIANT IN SYSTEMIC LUPUS ERYTHEMATOSUS - ABSTRACT DYSREGULATED TYPE I INTERFERON (IFN I) HAS BEEN ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATO… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | OK-90 | 2025 | $3,130,679 |
ASST_NON_R01AG064951_075 DOES INSULIN SENSITIVITY IMPACT THE POTENTIAL OF METFORMIN TO SLOW AGING? - SUMMARY NIA ISSUED PA-18-025 TO EXPLORE “…CLINICAL TRANSLATIONAL POTENTIAL OF METFORMIN TO DELAY DELETE… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | OK-90 | 2024 | $3,085,659 |
ASST_NON_R01AG074502_075 DETERMINING THE CONTEXT SPECIFICITY OF METFORMIN TREATMENT ON MUSCLE MITOCHONDRIA AND HEALTHSPAN - SUMMARY METFORMIN, THE MOST WIDELY PRESCRIBED MEDICATION FOR TREATING TYPE 2 DIA… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $3,047,633 |
ASST_NON_R01AI137047_075 UNDERSTANDING THE ROLES TYPE I INTERFERON AND TH17 PLAY IN NEUROMYELITIS OPTICA AND OTHER AUTOIMMUNE DISEASES. - SUMMARY: NEUROMYELITIS OPTICA (NMO) IS A RARE BUT DEVASTATING INF… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $2,803,140 |
ASST_NON_R01AG059430_075 SEX DIVERGENCE AND CELL SPECIFICITY OF AGE-RELATED HIPPOCAMPAL DNA MODIFICATIONS - ABSTRACT EPIGENETIC PROCESSES IN THE CENTRAL NERVOUS SYSTEM MAY PLAY A MECHANISTIC ROLE IN SUSCE… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | OK-90 | 2025 | $2,709,556 |
ASST_NON_U01AG055133_075 MOTRPAC: UC PRECLINICAL ANIMAL STUDY SITE - PROJECT SUMMARY/ABSTRACT THE UNIVERSITY OF CALIFORNIA PRECLINICAL ANIMAL STUDY SITE (UC PASS) IS A COLLABORATIVE EFFORT BETWEEN UC DAVI… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | OK-90 | 2024 | $2,700,584 |
ASST_NON_R01AI129458_075 CHARACTERIZATION OF A DISTINCT NKT SUBSET AND ITS ROLE IN INFLUENZA RESPONSES - ABSTRACT INVARIANT NATURAL KILLER T CELLS (NKT CELLS) ARE A CONSERVED T CELL POPULATION THAT BEHAV… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | OK-90 | 2025 | $2,689,431 |
ASST_NON_R01AR074310_075 SPECIFICITY AND MOLECULAR DEFINITION OF PATHOGENIC LYMPHOCYTES IN SJOGREN'S SYNDROME - PROJECT SUMMARY SJÖGREN'S SYNDROME (SS) IS A RHEUMATIC AUTOIMMUNE DISEASE SELECTIVELY TARGET… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | OK-90 | 2024 | $2,656,024 |
ASST_NON_R35GM137921_075 MECHANISMS OF MITOCHONDRIAL SUBPOPULATION FORMATION AND MAINTENANCE - PROJECT SUMMARY MITOCHONDRIA REGULATE SEVERAL CRITICAL CELLULAR PATHWAYS INCLUDING ENERGY HOMEOSTASIS, CALCIU… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | OK-90 | 2024 | $2,653,875 |
ASST_NON_R01AG074551_075 DISSECTING THE INTEGRATED MECHANISMS OF PROTEIN TURNOVER TO PREVENT PROTEOSTATIC DECLINE WITH AGING - SUMMARY PROTEOSTATIC MECHANISMS FAIL WITH ADVANCING AGE, RESULTING IN THE ACC… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $2,639,171 |
ASST_NON_R01HL167656_075 CARDIOVASCULAR RISK OF ANTIRETROVIRAL THERAPY DRUGS IN HIV - PROJECT SUMMARY ALTHOUGH ANTIRETROVIRAL THERAPY DRUGS (ART) HAVE PREVENTED HIV PROPAGATION AND INCREASED LIFE EXPECTAN… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $2,636,236 |
ASST_NON_RF1AG090599_075 A ROLE FOR MITOCHONDRIAL AMPK SIGNALING IN NEURONS - PROJECT SUMMARY AN EARLY HALLMARK OF ALZHEIMER’S DISEASE (AD) IS A LOSS OF NEURONAL CONNECTIVITY REFLECTED BY DECREASED DENDRI… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | OK-90 | 2025 | $2,602,940 |
ASST_NON_R01AG070035_075 ROLE OF ESTROGEN RECEPTOR-A IN AGING AND SEX-SPECIFIC RESPONSES TO 17A-ESTRADIOL - PROJECT SUMMARY/ABSTRACT SEVERAL PHARMACOLOGICAL COMPOUNDS HAVE SHOWN PROMISE AS INTERVENTIONAL… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $2,564,520 |
ASST_NON_UM1AI144292_075 OKLAHOMA ACE: MOLECULAR DESTRUCTION OF AUTOIMMUNE DISEASE TO AID CLINICAL TRAIL SUCCESS - PROJECT SUMMARY THE OKLAHOMA AUTOIMMUNITY CENTER OF EXCELLENCE AIMS TO UNDERSTAND AUTOIM… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | OK-90 | 2024 | $2,546,879 |
ASST_NON_P20GM156711_075 CENTER FOR GENOMIC REGULATION - ABSTRACT – OVERVIEW PROPER REGULATION OF GENOMIC STRUCTURE AND FUNCTION IS CENTRAL TO LIFE AND HEALTH. DYSFUNCTION OF CELL DIVISION, CHROMATIN STRU… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | OK-90 | 2025 | $2,463,036 |
ASST_NON_R01EY033782_075 INTERROGATING THE INTERSECTION BETWEEN DIET AND OCULAR AUTOIMMUNITY - 5-8% OF THE US POPULATION SUFFERS FROM AT LEAST ONE AUTOIMMUNE DISEASE. AN UPWARD TRAJECTORY HAS OCCURRED IN… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $2,251,397 |
ASST_NON_R01AG077812_075 A NOVEL ROLE FOR OXIDIZED LIPID MEDIATORS AS EFFECTORS OF MUSCLE ATROPHY AND WEAKNESS IN AGING - ABSTRACT. SARCOPENIA, THE LOSS OF MUSCLE MASS AND FUNCTION WITH AGE, IS A UNIVERSA… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $2,237,840 |
ASST_NON_R01AI172255_075 CONTRIBUTIONS OF AUTOPHAGY-RELATED GENES IN LUPUS - ABSTRACT LUPUS OR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IS A POTENTIALLY FATAL AUTOIMMUNE DISEASE WITH A SUBSTANTIAL GENETIC BASIS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $2,228,235 |
ASST_NON_DP5OD033443_075 SEX CHROMOSOMAL REGULATION OF HIPPOCAMPAL MICROGLIAL ACTIVATION WITH ALZHEIMER'S DISEASE AND AGING - ABSTRACT SEX AND AGE ARE THE PRIMARY RISK FACTORS FOR ALZHEIMER’S DISEASE (AD)… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | OK-90 | 2024 | $2,185,000 |
ASST_NON_R01NS121298_075 ROLE OF ATAD3A IN LYSOSOMAL HOMEOSTASIS AND NEUROGENESIS - PROJECT SUMMARY/ABSTRACT ATAD3A (ATP FAMILY AAA-DOMAIN CONTAINING PROTEIN 3A) IS A MITOCHONDRIAL MEMBRANE PROTEIN THAT I… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | OKLAHOMA CITY, OK-05 | 2024 | $2,172,201 |
ASST_NON_R01EY027346_075 PATHOGENIC B CELL AND T HELPER CELL INTERACTIONS IN NEUROMYELITIS OPTICA - SUMMARY: NEUROMYELITIS OPTICA (NMO) IS A RARE BUT DEVASTATING INFLAMMATORY DISORDER OF THE CENTRAL NERV… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $2,168,162 |
ASST_NON_R01GM141040_075 DISCOVERY AND CHARACTERIZATION OF NOVEL SEPSIS PROTEOME BIOMARKERS - ABSTRACT THIS PROJECT WILL USE MASS SPECTROMETRY-BASED PROTEOMICS FOR BIOMARKER DISCOVERY AND VALIDATION AND W… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | OK-90 | 2024 | $2,161,040 |
ASST_NON_R01HL163095_075 NOVEL LYMPHATIC GENES THAT REGULATE HEART VALVE DEVELOPMENT AND DISEASE - PROJECT SUMMARY/ABSTRACT VALVES ARE PRESENT WITHIN HEARTS, VEINS AND LYMPHATIC VESSELS TO REGULATE THE FL… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $2,151,114 |
ASST_NON_R01EB025596_075 A 3D HUMAN TISSUE-ENGINEERED LUNG MODEL TO STUDY IMMUNE RESPONSES TO RESPIRATORY SYNCYTIAL VIRUS - RESPIRATORY SYNCYTIAL VIRUS (RSV) IS THE LEADING CAUSE OF VIRAL BRONCHIOLITIS AN… | Department of Health and Human Services National Institutes of Health | 93.286 DISCOVERY AND APPLIED RESEARCH FOR TECHNOLOGICAL INNOVATIONS TO IMPROVE HUMAN HEALTH | OK-90 | 2025 | $2,140,632 |
ASST_NON_R01HL148123_075 THE ROLE OF TGF-BETA ACTIVATION AND SIGNALING IN AORTIC STENOSIS PROGRESSION - PROJECT SUMMARY AORTIC STENOSIS (AS) IS A DEGENERATIVE HEART CONDITION CHARACTERIZED BY FIBROSIS AND… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | OK-90 | 2025 | $2,079,053 |
ASST_NON_R01AR080896_075 PDGFRB SIGNALING IN PROGRESSIVE SKIN DISEASE - PROJECT SUMMARY/ABSTRACT SOLVING THE PATHOGENESIS OF RARE GENETIC DISEASES LEADS TO GREATER UNDERSTANDING OF BASIC PHYSIOLOGY AND GE… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | OKLAHOMA CITY, OK-05 | 2024 | $2,051,242 |
ASST_NON_R35GM142726_075 MECHANISMS OF APP ECTODOMAIN FUNCTION - PROJECT SUMMARY CELL MEMBRANE PROTEINS REGULATE A MULTITUDE OF CELLULAR PROCESSES THAT ARE VITAL FOR ORGANISMAL HEALTH. THE EXTRACELLULAR D… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | OKLAHOMA CITY, OK-05 | 2024 | $2,044,538 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→1234567
ADMINISTRATIVE MANAGEMENT AND GENERAL MANAGEMENT CONSULTING SERVICES$193K
VETERINARY SERVICES$92K
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$39K
DIAGNOSTIC IMAGING CENTERS$18K
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)$17K
TESTING LABORATORIES AND SERVICES$8K
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES$6K
Federal Programs (CFDA)
View All→12345678910
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$78.9M
93.859 — BIOMEDICAL RESEARCH AND RESEARCH TRAINING$76.5M
93.846 — ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH$51.5M
93.837 — CARDIOVASCULAR DISEASES RESEARCH$46.2M
93.866 — AGING RESEARCH$29.0M
93.867 — VISION RESEARCH$6.0M
93.493 — CONGRESSIONAL DIRECTIVES$5.7M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$5.4M
93.310 — TRANS-NIH RESEARCH SUPPORT$5.1M
93.121 — ORAL DISEASES AND DISORDERS RESEARCH$4.2M
Source: USAspending.gov · All Recipients · Oklahoma